[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335342-105":59,"doc-detail-335342-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","grem1-may-be-a-biological-indicator-and-potential-target-of-bladder-cancer","GREM1 may be a biological indicator and potential target of bladder cancer","","Gremlin 1 (GREM1) regulates the development of many cancers, and its relevance to bladder cancer (BC) is evaluated by combining bioinformatics analyses with experimental validation. Using R 3.6.3 and multiple public datasets, GREM1 is shown to be highly expressed in BC tissues, with significant prognostic value for patients. Pathway analysis links GREM1 to immune and metabolism processes, and TIDE results suggest low-GREM1 tumors respond better to immunotherapy. Elevated GREM1 also aligns with sensitivity to several chemotherapy drugs, supporting biomarker and therapeutic-target potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/grem1-may-be-a-biological-indicator-and-potential-target-of-bladder-cancer/335342/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/grem1-may-be-a-biological-indicator-and-potential-target-of-bladder-cancer/335342.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was GREM1 expression evaluated in bladder cancer?","Question",{"text":112,"@type":113},"Expression data were extracted from online databases, and differences were analyzed using the limma package. Immunohistochemical staining on institutional samples was used to validate the results.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What prognostic value does GREM1 have for bladder cancer patients?",{"text":117,"@type":113},"TCGA and other datasets plus IHC data indicate that GREM1 has significant prognostic value for bladder cancer patients.",{"name":119,"@type":110,"acceptedAnswer":120},"How does GREM1 relate to immunotherapy and chemotherapy response?",{"text":121,"@type":113},"TIDE analysis shows a higher immunotherapy response rate in patients with low GREM1 expression. High GREM1 expression is associated with sensitivity to cisplatin, docetaxel, gemcitabine, and vinblastine.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335342,1790241196,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nGREM1 may be a biological indicator and potential target of bladder cancer  \nQingxin Yu1,4􀀍, Shanshan Xu1,4, Shouxiang Weng2, Luxia Ye2, Haihong Zheng2,4􀀍 & Dengxiong Li3,4􀀍  \nGremlin 1 (GREM1) can regulate the development of many cancers. However, a few studies have revealed the role ofGREM1 in bladder cancer (BC). To evaluate the expression and potential function of GREM1 in bladder cancer, we used R version 3.6.3 and related packages to analyze the data from common databases. Samples from our institution were assessed by immunohistochemical staining (IHC), which was approved by the Institutional Ethics Committee (K20220830). GREM1 was highly expressed in BC tissues according totheTCGA and IHC data. Data from TCGA, GSE31684, GSE32894, and IHC showed that GREM1 has significant prognostic value for BC patients. GREM1 is involved in immune and metabolism-related pathways. According to the TIDE algorithm, 61.0% of patients with low GREM1 expression responded well to immunotherapy, compared to only 13.3% in the high GREM1 expression group. High GREM1 expression was associated with sensitivity to cisplatin, docetaxel, gemcitabine, and vinblastine. Thus, GREM1 can predict prognosis and responses to immunotherapy and chemotherapy in BC patients, making it a potential biomarker and therapeutic target.  \nKeywords GREM1, Bladder cancer, Immune, Biomarker  \nBladder cancer (BC) ranks as the 6th most common cancer in men1. Several factors contribute to the carcinogenesis of the bladder, including smoking2, employment in dye factories3, arsenic exposure4, and soon. According to the pathological manifestations, BC is clinically divided into nonmuscle-invasive BC and muscle-invasive BC5–7. Although multiple molecular subtypes have been reported, there is no consensus on the classification of molecular subtypes in clinical classes because BC is a highly heterogeneous disease8,9. With the continuous efforts of researchers, various treatments (including surgery, chemotherapy, radiotherapy, and immunotherapy) have been used to improve the prognosis of patients with BC10, 11. Many problems appear with the application of these treatments. Radical cystectomy brings heavy economic, physical, and mental burdens to BC patients12, 13. Many patients are resistant to chemotherapy and immunotherapy due to the high heterogeneity of BC14, 15. Meanwhile, the efficiency of these treatments is still unsatisfactory. These puzzles promote the emergence of precision medicine16, 17. Under the instruction of precision medicine, researchers find new medicine by screening targets18–20. On the other hand, doctors can choose the optimal therapy plan for each BC patient and reduce the cost of treatment while treating BC efficiently21,22.  \nGremlin1 (GREM1), a highly conserved secreted protein, is required in the process of embryogenesis23–25. GREM1 can inhibit the activation of BMP signaling by binding to BMP2, BMP4 or BMP7 to form heterodimers26. Recently, some studies reported that GREM1 was highly expressed in tumor tissues and could regulate the progression of tumors. The epithelial-mesenchymal transition (EMT) induced by GREM1 was the cause of poor prognosis in patients with high GREM1 expression27,28. GREM1 acts as an oncogene in many cancers, such as prostate cancer29, glioma30, colorectal cancer31–33, lung cancer34, and esophageal squamous cell carcinoma28. However, in pancreatic ductal adenocarcinoma, GREM1 is required to maintain cellular heterogeneity in tumorsand can restrict EMT by inhibiting the expression of the EMT transcription factors Snai1 and Snai235. Loss of GREM1 promotes the metastasis of pancreatic ductal adenocarcinoma, and GREM1 is a tumor suppressor gene in pancreatic ductal adenocarcinoma35. Furthermore, a study identified that knockdown of GREM1 could improve the chemotherapy sensitivity of cervical squamous carcinoma cells36. Zhu et al.29 reported that GREM1 was","cbCaifumFFjLyjQD","https://ap.wps.com/l/cbCaifumFFjLyjQD","pdf",6657213,13,"English","# Background\n# Role of GREM1 in cancer and rationale for BC study\n# Study design and methods\n## Data acquisition from online databases\n## Immunohistochemical validation and clinical assessment\n## Evaluation in immunotherapy and chemotherapy","[{\"question\":\"How was GREM1 expression evaluated in bladder cancer?\",\"answer\":\"Expression data were extracted from online databases, and differences were analyzed using the limma package. Immunohistochemical staining on institutional samples was used to validate the results.\"},{\"question\":\"What prognostic value does GREM1 have for bladder cancer patients?\",\"answer\":\"TCGA and other datasets plus IHC data indicate that GREM1 has significant prognostic value for bladder cancer patients.\"},{\"question\":\"How does GREM1 relate to immunotherapy and chemotherapy response?\",\"answer\":\"TIDE analysis shows a higher immunotherapy response rate in patients with low GREM1 expression. High GREM1 expression is associated with sensitivity to cisplatin, docetaxel, gemcitabine, and vinblastine.\"}]","GREM1 may be a biological indicator and potential target of bladder cancer | PDF",1790010618,33]